Should duration of dual antiplatelet therapy depend on the type and/or potency of implanted stent? A pre-specified analysis from the PROlonging Dual antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY (PRODIGY)

2008, Journal of the American College of Cardiology, 51, 172, 10.1016/j.jacc.2007.10.002

2010, European Heart Journal, 31, 2501, 10.1093/eurheartj/ehq277

Joner, 2008, Journal of the American College of Cardiology, 52, 333, 10.1016/j.jacc.2008.04.030

2010, JACC CARDIOVASC INTERVEN, 3, 1043, 10.1016/j.jcin.2010.07.008

Stone, 2010, New England Journal of Medicine, 362, 1663, 10.1056/NEJMoa0910496

2011, JACC CARDIOVASC INTERVEN, 4, 1119

2012, JACC CARDIOVASC INTERVEN, 5, 626

Valgimigli, 2010, American heart journal, 160, 804, 10.1016/j.ahj.2010.07.034

2012, Circulation, 125, 2015, 10.1161/CIRCULATIONAHA.111.071589

Cutlip, 2007, Circulation, 115, 2344, 10.1161/CIRCULATIONAHA.106.685313

2011, JACC CARDIOVASC INTERVEN, 4, 778, 10.1016/j.jcin.2011.04.007

2010, JACC CARDIOVASC INTERVEN, 3, 531

2009, JACC CARDIOVASC INTERVEN, 2, 1240, 10.1016/j.jcin.2009.10.006

Kedhi, 2012, 8, 599, 10.4244/EIJV8I5A92

2007, Circulation, 115, 1440, 10.1161/CIRCULATIONAHA.106.666800

Ellis, 1990, Circulation, 82, 1193, 10.1161/01.CIR.82.4.1193